MAIA Biotechnology, Inc. (MAIA) has 58 open-market insider trades by 10 insiders since 2022. Over the last six months insiders net bought $556K. The most active filer is Stan Smith, Director.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Stan Smith | Dir | — | 17 | $3.4M | 2026-06-01 |
| Ramiro Guerrero | Dir | — | 14 | $1.4M | 2026-09-10 |
| Ngar Yee Louie | Dir | — | 5 | $847K | 2025-12-22 |
| Vlad Vitoc | CEO10% Owner | — | 7 | $440K | 2026-09-14 |
| Cristian Luput | Dir | — | 5 | $327K | 2025-11-28 |
| Steven M. Chaouki | Dir | — | 4 | $226K | 2025-12-22 |
| Joseph F. McGuire | CFO | — | 2 | $35K | 2023-04-27 |
| Laurentiu Vlad | Dir | — | 1 | $25K | 2022-08-01 |
| Sergei Gryaznov | CSO | — | 2 | $18K | 2026-06-01 |
| Mihail Obrocea | Chief Medical Officer | — | 1 | $5K | 2022-08-01 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Vlad Vitoc | CEO & 10% Owner | Buy | $100K | 2026-09-14 |
| Ramiro Guerrero | Director | Buy | $50K | 2026-09-10 |
| Ramiro Guerrero | Director | Buy | $184K | 2026-08-26 |
| Ramiro Guerrero | Director | Buy | $2K | 2026-08-24 |
| Ramiro Guerrero | Director | Buy | $16K | 2026-08-20 |
| Vlad Vitoc | CEO & 10% Owner | Buy | $101K | 2026-06-01 |
Companies that share insiders with MAIA, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Sergei Gryaznov | CSO | Buy | $3K | 2026-06-01 |
| Stan Smith | Director | Buy | $100K | 2026-06-01 |
| Ngar Yee Louie | Director | Buy | $199K | 2025-12-22 |
| Stan Smith | Director | Buy | $140K | 2025-12-22 |
| Steven M. Chaouki | Director | Buy | $50K | 2025-12-22 |
| Stan Smith | Director | Buy | $11K | 2025-12-05 |
| Stan Smith | Director | Buy | $16K | 2025-11-26 |
| Vlad Vitoc | CEO | Buy | $137K | 2025-11-26 |
| Cristian Luput | Director | Buy | $42K | 2025-11-26 |